FDA Adverse Event Malfunction Summary report: N

BD BBL¿ TB CARBOLFUCHSIN KF

MDR report key: 21382030 · Received February 13, 2025

Report

Report Number
1119779-2025-00070
Event Type
Malfunction
Date Received
February 13, 2025
Date of Event
January 15, 2025
Report Date
February 28, 2025
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
ICL
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY - THIS MEMO IS TO SUMMARIZE FINDINGS ON THE COMPLAINT RELATED TO BOTTLE TB CARBOLFUCHSIN KF 250 ML, CATALOG NUMBER 212518, BATCH NUMBER 4100006, AND COMPLAINT NUMBER (B)(6) FOR PERFORMANCE. COMPONENTS ARE MIXED AND DISPENSED INTO CONTAINERS. FOLLOWING QC RELEASE, AND BASED UPON INVENTORY DEMAND, FINAL PACKAGING OPERATIONS OCCUR FOLLOWED BY TRANSPORT TO THE DISTRIBUTION CENTER. THE COMPLAINT INVESTIGATION INCLUDED A REVIEW OF THE BATCH HISTORY RECORD FOR TB CARBOLFUCHSIN KF. THE BATCH HISTORY RECORD REVIEWS INDICATED NO DISCREPANCIES. ALL RELEASE TESTING WAS SATISFACTORY. COMPLAINT TRENDS WERE REVIEWED FOR A PERIOD COVERING 12 MONTHS. DURING THAT TIME THERE HAVE BEEN NO CONFIRMED COMPLAINTS FOR THE DEFECT IN QUESTION. TWO PHOTOS WERE ATTACHED IN LIEU OF RETURN. ALL PHOTOS DEPICT A DIFFERENT MICROSCOPE VIEW OF ACID-FAST STAIN BACTERIA. BD BBL¿ TB STAIN KITS ARE USED TO MANUALLY STAIN SMEARS PREPARED FROM SPECIMENS AND CULTURES SUSPECTED OF CONTAINING MYCOBACTERIA, ESPECIALLY MYCOBACTERIUM TUBERCULOSIS, FOR QUALITATIVE EARLY PRESUMPTIVE DIAGNOSIS OF MYCOBACTERIAL INFECTION AND CHARACTERIZATION OF BACTERIAL ISOLATES. SLIDES OF POSITIVE (M. TUBERCULOSIS ATCC 25177) AND NEGATIVE (B. SUBTILIS ATCC 6533) CONTROLS WERE EVALUATED AND GAVE SATISFACTORY STAINING RESULTS AT RELEASE OF THE PRODUCT. FROM CUSTOMER'S RESPONSE: ¿AFB QC SLIDES WERE USED AND PRODUCED EXPECTED RESULTS. POSITIVE CONTROL SLIDE HAD PINK/RED ACID-FAST BACILLI. NEGATIVE CONTROL SLIDE HAD GREENISH-BLUE BACKGROUND¿. THE ORGANISM DESCRIBED IN THE COMPLAINT REPORT IS NOCARDIA. BD DOES NOT HAVE ESTABLISHED RELEASE REQUIREMENTS OR PERFORMANCE DATA FOR STAINING NOCARDIA. BASED ON THE LIMITATIONS OF THE PROCEDURE AND RELEASE SPECIFICATIONS FOR THE PRODUCT, WE ARE UNABLE TO FURTHER REPLICATE THE CUSTOMER¿S APPLICATION WITH THIS PRODUCT. THIS COMPLAINT CANNOT BE CONFIRMED. BD WILL CONTINUE TO TREND ON PERFORMANCE ISSUES.

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF, ONE PATIENT SAMPLE HAD BRANCHING ORGANISMS THAT STAINED KINYOUN POSITIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD BBL¿ TB CARBOLFUCHSIN KF, ONE PATIENT SAMPLE HAD BRANCHING ORGANISMS THAT STAINED KINYOUN POSITIVE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1460092 BD BBL¿ TB CARBOLFUCHSIN KF CARBOL FUCHSIN ICL BECTON DICKINSON & CO. (SPARKS) 4100006

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown